Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
Journalists
Submit Release
January 24, 2009
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Websites.
 
Close Move
All Press Releases for April 3, 2007 Subscribe to this News Feed    
 

American Kidney Fund Launches Medicare Part D Grant Program for Prescription Bone Disease Medications

Program will help dialysis patients with 'donut hole' and other costs.

Rockville, MD (Vocus/PRWEB ) April 3, 2007 -- The American Kidney Fund (AKF), www.kidneyfund.org, the nation's #1 source of financial assistance to kidney patients, announced today that it is initiating a new program to help qualified dialysis patients pay for prescription bone disease medications under Medicare Part D.

Under the program, eligible patients may receive up to $2,000 per year in prescription assistance for bone disease medications. Most significantly, the program will help qualified dialysis patients with coverage gap ("donut hole") costs. For patients who are not currently in the "donut hole" phase of Part D, the grants can be applied to the patient share of the cost to obtain bone disease medications.

This program covers common bone disease medications, including Fosrenol®, Hectorol®, Phoslo®, Renagel®, Sensipar® and Zemplar®.

"We are extremely pleased that we are able to help dialysis patients with an urgent financial need that has arisen under Medicare Part D," said LaVarne A. Burton, Chief Executive Officer of the American Kidney Fund. "Because they take so many prescription medications, many dialysis patients have fallen into the Part D 'donut hole' coverage gap, under which they must bear the full cost of their medications until they reach a certain out-of-pocket spending level. This program will provide urgently needed assistance to eligible patients who are in that situation--as well as to patients who are in the other phases of Part D coverage."

The kidneys are essential to healthy bones because the kidneys regulate levels of calcium, vitamin D, and phosphorus in the blood. Bone disease, which can cause bone pain and fractures, is common in people whose kidneys have failed.

"In the future, we hope to be able to introduce additional programs that will assist dialysis patients with paying for other types of medications under Medicare Part D," Burton said. "Bone disease is just one of the co-morbid conditions associated with kidney disease. These other conditions, which include cardiovascular disease and anemia, require medications that can be very expensive. Kidney failure imposes a great economic hardship on many people, and through our programs, we are working to ease that burden."

The Part D Grant Program is the American Kidney Fund's newest effort to help patients with the high costs of treating kidney disease. In partnership with the nation's dialysis providers, AKF offers a Health Insurance Premium Program that helps dialysis patients maintain their health insurance coverage. The organization offers numerous grant programs to assist with out-of-pocket costs, such as the cost of transportation to dialysis and the cost of over-the-counter medicines.

Last year, AKF provided $81.9 million in grant assistance to 63,500 people, nearly one-fifth of the nation's dialysis patients. All AKF grant programs are subject to strict eligibility guidelines. AKF provides assistance to people who have exhausted every other means of aid.

AKF also maintains a robust program of kidney disease education and prevention. In the past three years, AKF has provided free kidney health screenings to nearly 11,000 people in Atlanta, Chicago and Washington, D.C.--three cities with very high rates of kidney failure. The organization runs public awareness campaigns and offers a brochure series and toll-free HelpLine (866-300-2900) to promote public understanding of kidney disease.

Details on the AKF Part D grant program, including eligibility guidelines, can be found at www.kidneyfund.org. Patients who are interested in applying for assistance should contact the social workers at their dialysis centers for details. To receive an application in the mail, call the AKF Patient Services department at 1-800-638-8299.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/UHJvZi1FbXB0LVNpbmctQ3Jhcy1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Tamara Ruggiero
American Kidney Fund
301-984-6657
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2009, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright